Browse Category

Artificial Intelligence News 29 January 2026

IBM stock jumps today after earnings beat as investors weigh AI demand and Red Hat slowdown

IBM stock jumps today after earnings beat as investors weigh AI demand and Red Hat slowdown

IBM shares rose 3.9% to $305.65 Thursday after quarterly results beat estimates and the company reaffirmed its 2026 outlook. The gains stood out as software stocks broadly slumped, with SAP down over 16% and ServiceNow off 11%. IBM reported fourth-quarter revenue of $19.7 billion and announced a $1.68 dividend. Major indexes fell to their lowest in more than a week amid tech sector concerns.
Microsoft stock dives 12% on AI spending jitters as Meta jumps — AI stocks split today

Microsoft stock dives 12% on AI spending jitters as Meta jumps — AI stocks split today

Microsoft shares fell nearly 12% after cloud growth and AI spending figures disappointed, dragging down other AI stocks. Meta jumped about 10% on strong ad sales and a higher 2026 capex forecast. Nvidia slipped 0.6%, Amazon lost 1.6%, and Apple was flat ahead of its earnings report. Traders are also watching reported OpenAI funding talks involving Microsoft, Nvidia, and Amazon.
Dow Jones slips as Microsoft earnings jolt the AI trade; Apple results loom

Dow Jones slips as Microsoft earnings jolt the AI trade; Apple results loom

By 1:31 p.m. EST, the Dow Jones Industrial Average had dropped 143.74 points to 48,871.86, while the S&P 500 and Nasdaq fell 0.73% and 1.46%. Microsoft plunged 12.2% after weak cloud revenue, pulling the Dow lower. Oil prices rose over 2% amid concerns about a possible U.S. strike on Iran. Apple is set to report its strongest iPhone sales growth in four years after the bell.
Microsoft stock price tumbles 12% as record AI spending and Azure outlook rattle Wall Street

Microsoft stock price tumbles 12% as record AI spending and Azure outlook rattle Wall Street

Microsoft shares fell 12% to $423.78 Thursday as investors reacted to soaring AI spending and questions over cloud growth. Quarterly revenue rose 17% to $81.3 billion, while capital spending jumped 66% to $37.5 billion, mostly on chips. The sell-off followed Microsoft’s disclosure that 45% of its cloud backlog is tied to OpenAI. CFO Amy Hood cited AI chip constraints as a limit on Azure growth.
Salesforce stock dives as software selloff deepens on AI disruption fears — what investors watch next

Salesforce stock dives as software selloff deepens on AI disruption fears — what investors watch next

Salesforce shares fell 6.5% to $213.12 Thursday amid a broad software selloff after weak results from SAP and ServiceNow. The S&P 500 Software and Services index dropped 8.7%, hitting a nine-month low. Investors cited concerns over Big Tech’s AI spending and slower cloud growth. SAP and ServiceNow both issued forecasts that failed to lift sector sentiment.
Seagate (STX) stock price slips after record rally on AI-driven outlook — what to watch next

Seagate (STX) stock price slips after record rally on AI-driven outlook — what to watch next

Seagate shares fell 1.1% to $438.09 by late morning Thursday, after a 19% surge to a record high on strong earnings and AI-driven storage demand. The company projected March-quarter revenue of $2.90 billion and adjusted EPS of $3.40, beating analyst estimates. Nearline capacity is fully allocated through 2026, with pricing set to follow demand. The board declared a $0.74 dividend, payable April 8 to holders as of March 25.
Microsoft stock dives as AI spending bites; Nvidia steady, Meta jumps in split AI trade

Microsoft stock dives as AI spending bites; Nvidia steady, Meta jumps in split AI trade

Microsoft fell 10.7% to $429.87 after reporting record AI spending and slower cloud growth, triggering a broader dip among AI stocks. Meta rose 7.9% on a higher 2026 capex forecast, betting ad revenue will fund its AI push. Reports surfaced that Big Tech could invest up to $60 billion more in OpenAI, intensifying scrutiny of AI costs.
Microsoft stock slides 10% after earnings beat as Azure outlook, AI bill unsettle Wall Street

Microsoft stock slides 10% after earnings beat as Azure outlook, AI bill unsettle Wall Street

Microsoft shares fell about 10% Thursday after the company reported record AI-driven capital spending and forecast strong Azure growth. Quarterly revenue rose 17% to $81.3 billion, with cloud revenue up 39%. Investors focused on soaring costs, which climbed nearly 66% year-over-year. Apple is set to report earnings later Thursday.
Sandisk stock price rises ahead of earnings as AI storage trade stays in focus (SNDK)

Sandisk stock price rises ahead of earnings as AI storage trade stays in focus (SNDK)

Sandisk shares rose 1% to $532.99 Thursday morning ahead of its fiscal Q2 results due after market close. Seagate and Western Digital also gained, while Micron slipped. Analysts expect Sandisk to report $2.7 billion in revenue and $3.62 adjusted EPS. Investors are focused on the company’s outlook for NAND pricing and data-center demand.
Meta stock jumps about 9% as Zuckerberg bets big on “superintelligence” spending

Meta stock jumps about 9% as Zuckerberg bets big on “superintelligence” spending

Meta shares rose 9.3% to $731.18 in early U.S. trading after reporting Q4 revenue up 24% to $59.89 billion and issuing a strong revenue forecast. The company raised its 2026 capital spending target to as much as $135 billion, citing major investments in AI. Costs jumped 40%, cutting operating margin to 41%. Meta projects full-year 2026 expenses up to $169 billion, warning of legal and regulatory risks.
Apple stock slips as earnings loom; iPhone sales and Siri AI push in sharp focus

Apple stock slips as earnings loom; iPhone sales and Siri AI push in sharp focus

Apple shares fell 0.7% to $256.44 in early New York trading Thursday ahead of quarterly earnings due after the bell. Investors are focused on iPhone sales, rising memory costs, and updates to Siri using Google’s AI. Analysts expect record revenue and the strongest iPhone growth in four years, led by China demand. Regulatory scrutiny of Apple’s services continues.
Microsoft stock drops in premarket after record AI spend puts Azure payoff in focus

Microsoft stock drops in premarket after record AI spend puts Azure payoff in focus

Microsoft shares fell 5.7% to about $454 in premarket trading Thursday after its quarterly report highlighted a 66% jump in capital spending, mainly for AI infrastructure. Revenue rose 17% to $81.3 billion, with cloud sales up 26%. Investors expressed concern over rising costs outpacing sales growth and potential pressure on cloud margins from higher chip prices.
Meta stock price jumps after earnings — but $135 billion AI capex is the new battleground

Meta stock price jumps after earnings — but $135 billion AI capex is the new battleground

Meta shares surged nearly 7% in early Frankfurt trading after the company reported a 24% jump in Q4 revenue to $59.89 billion and issued a strong Q1 forecast. Meta raised its 2026 capital expenditure guidance to $115–$135 billion, citing increased investment in AI infrastructure. Operating margin fell to 41% from 48% a year earlier. Investors weighed robust ad sales against rising costs and regulatory pressures.
Caterpillar stock edges up ahead of earnings as AI data-center power deal puts CAT in focus

Caterpillar stock edges up ahead of earnings as AI data-center power deal puts CAT in focus

Caterpillar shares closed Wednesday up 0.7% at $643.28 after landing a 2-gigawatt data-center power contract and an analyst price target hike. The company will report fourth-quarter and full-year results before the U.S. market opens Thursday. Investors await earnings guidance as analysts expect a 9% year-over-year profit drop.
Mastercard stock price ticks up after-hours as earnings near; AI “Agent Suite” lands in the mix

Mastercard stock price ticks up after-hours as earnings near; AI “Agent Suite” lands in the mix

Mastercard shares edged up 0.2% to $521.37 in after-hours trading Wednesday ahead of Thursday’s earnings report. Analysts expect quarterly earnings of $4.20 per share. The company announced its “Agent Suite” AI tools, set to launch in the second quarter, and completed Australia’s first authenticated agentic transactions. Visa rose 0.5%, while American Express slipped 0.7%.
AMD stock price: After-hours uptick as AI-chip rally rolls on ahead of Feb. 3 earnings

AMD stock price: After-hours uptick as AI-chip rally rolls on ahead of Feb. 3 earnings

AMD shares rose 0.3% to $252.74 in after-hours trading Wednesday, while Nvidia gained 1.6% and Intel jumped 11%. Chip stocks rallied after China approved ByteDance, Alibaba, and Tencent to buy over 400,000 Nvidia H200 AI chips, signaling strong AI data-center demand. The Philadelphia Semiconductor Index climbed 1.7%. Investors await AMD’s earnings on Feb. 3 for further signals on sector momentum.
1 13 14 15 16 17 144

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop